C

Cellectis SA
D

CLLS

1.59000
USD
-0.05
(-3.05%)
مغلق
حجم التداول
1,581
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
159,517,114
أصول ذات صلة
AMGN
AMGN
1.79
(0.60%)
298.52 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
C
CLDX
-0.150
(-0.68%)
21.950 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
J
JAZZ
-0.420
(-0.38%)
109.520 USD
NVS
NVS
-1.350
(-1.09%)
122.490 USD
المزيد
الأخبار المقالات

العنوان: Cellectis SA

القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.